Abstract: Canine papillomaviruses (CPVs) have been identified in various benign and malignant neoplastic skin disorders. The most frequent manifestations of CPV infections are classical warts and pigmented plaques. Although the etiology of canine oral papillomatosis is well established, knowledge about CPVs role in the development of pigmented plaques remains vague. Indeed, as CPV DNA may frequently be found on clinically healthy canine skin, its mere detection in lesions cannot be regarded as a sufficient indicator of causality. Whether CPVs are actually active in pigmented plaques, a requirement for any conceivable involvement, is consequently an open question. To enquire such viral activity, two distinct clinical cases of canine pigmented lesions were evaluated in greater detail. The histological findings in the two cases supported the clinical diagnosis of pigmented viral plaques. Sequencing of amplified DNA from these lesions revealed the genomes of two novel CPV types, i.e. CPV9 and CPV14, both putatively belonging to the genus Chi. Furthermore, transcription and splicing of corresponding CPV mRNA could be shown by RT-PCR in the respective lesions. Finally, viral particles were detected by electron microscopy in homogenates as well as in nuclei of keratinocytes in pigmented lesions. In conclusion, the results link clinical signs of pigmented plaques to histological changes, the presence of CPV specific DNA, viral gene transcription, and the presence of viral particles in and from the lesions. Thus, the findings outline the entire replicative cycle of CPVs in pigmented plaques, which might help understanding the relationship between these viruses and the associated disorders. 
Introduction
Identification, Amplification and cloning of genomes 137 Total DNA of 25 mg tissue samples was isolated using a DNeasy extraction kit (Qiagen) 138 according to the manufacturer's recommendations. For initial identification of host and PV
139
DNA in the samples GAPDH f/r, CP4/CP5 and canPV/FAP64 PCR assays were applied 140 (Iftner et al., 2003 , Lange et al., 2011 . PCR products were determined (Microsynth) by cycle 141 sequencing using an ABI 377 sequencer (Applied Biosystems) and compared to the NCBI 142 database (BLAST X). For cloning purposes one microliter of the DNA extract was used for 143 rolling circle amplification (RCA) (Rector et al., 2004) , using a TempliPhi Amplification kit 144 (General Electrics Biosciences). Slight modifications were applied to the protocol supplied by 145 the manufacturer (Lange et al., 2009) . Amplified DNA from case one (CPV14) was cloned 146 into the BamHI, EcoRI or XbaI site of pBluescript II KS+ (Stratagene), while the DNA 147 amplified from case two was cloned into the SalI site (CPV9) using standard procedures. The 148 cloned DNA sequences of the PV candidates were determined (Microsynth) and primary 149 sequences were assembled using Contigexpress software (Vector NTI Informax, Invitrogen).
150
The nucleotide sequence data of CPV14 were deposited in GenBank under accession no.
151

JQ701802.
153
Sequence analysis 154 The coding sequences for the E6, E7, E1, E2, L2 and L1 proteins from the CPVs, feline papillomaviruses (FdPVs) and bovine papillomavirus 1 (BPV1) were translated and aligned 156 by using MAFFT (Katoh and Toh, 2008) before being back-translated to DNA sequences.
157
The six sets of aligned nucleotide sequences representing the six sets of protein sequences 158 were shortened by using GBLOCK (version 0.91b; http://molevol.cmima.csic.es/castresana/) 159 (Castresana et al., 2000) and combined to a single multiple sequence alignment (MSA) by 160 concatenating the sequences from each virus. The optimal model of DNA evolution was 161 evaluated for best fit of the data set using MODELTEST (version 1.4.4; 162 http://darwin.uvigo.es/; default settings) (Posada 1998 (Drummond et al., 2007) . Pairwise sequence alignments were performed using NEEDLE
167
(EMBOSS, nucleotide matrix: DNAFULL, amino acid matrix: BLOSSUM62). Splice sites 168 were predicted by the on-line version of NETGENE2
169
(http://www.cbs.dtu.dk/services/NetGene2/) (Brunak et al., 1991) . according to the protocol to produce cDNA with random primers. To control the success of To test for RNA transcription, primer combinations amplifying fragments of the main 181 transcripts, E6, E7, E1, E2, E1^E4, L2 and L1 were constructed (supplement 2). Except for 182 E4 all primers were designed to amplify regions were no splicing was expected. The primers 183 for E1^E4 PCR however were designed to identify donor and acceptor splice sites of the 184 E1ˆE4 mRNA. PCR was performed on cDNA with and without RT, sterile water and DNA 185 extract of lesional tissue.
186
To determine the splice sites the E4 PCR product from the cDNA was extracted from the gel 187 using a QIAEX II kit (QIAGEN) and sequenced (Microsynth). The sequence of the putative 188 E4 of CPV14 was included in the file JQ701802. The putative E4 sequence information of 189 CPV9 was deposited separate in GenBank under accession no. JQ701801.
191
Results
192
Clinical development
193
The course of the papillomavirus infections after presentation varied significantly. The lesions 194 in the Golden retriever resolved entirely within few weeks despite of continued corticosteroid 195 treatment. In the pug on the contrary more lesions developed over the following months, but 196 no approach of treatment was attempted. (Fig. 1C) . A diagnosis of canine viral pigmented plaques was made.
203
The histological sections from the Golden retriever showed papillated hyperplasia and 204 hyperpigmentation of the epidermis with large clumped keratohyalin granules. They were also 205 found to contain disseminated apoptotic cells and some scattered clear cells reminiscent of 206 koilocytes in the stratum granulosum (Fig. 1D) . A papilloma was diagnosed. (Table 1) . CPV9 has a GC content of 51%, CPV14 of 53%.
223
Characteristic papillomavirus motifs were identified on the genomic sequences. 
Phylogeny
245
To allocate the two viral genomes in a phylogenetic context, they were compared to the other 246 canine and feline papillomaviruses and a bovine papillomavirus 1 sequence. In a phylogenetic 247 tree based on the E6, E7, E1, E2, L1 and L2 regions both CPVs appear in the branch of the
248
Chi papillomaviruses (Fig. 2) 
RNA & Splicing
258
To determine whether the viral genes were transcribed in the lesional tissue, total RNA was 259 extracted from fresh samples, reverse transcribed into cDNA and analyzed by PCR. Different
260
PCRs with specific primer sets were applied to amplify cDNA of the host GAPDH mRNA, as 261 well as of the viral mRNAs of L2, L1, E6, E7, E1, E2 and E1^E4 of CPV9 or CPV14
262
(supplement 2). The RT-PCR revealed amplimers of expected sizes. However, no product 263 was produced if the reverse transcriptase was omitted in the cDNA reaction (Fig. 3) .
264
Using the E1^E4 transcript specific primers, no PCR product of the expected size (3030 and 265 3159 bp, respectively; see supplement 2) was produced from the DNA extract of the lesions.
266
A side product of unknown origin was amplified with the CPV9 E1^E4 specific primer of could be shown by transmission electron microscopy and viral particles could also be visualized 329 using negative stain techniques (Fig. 4) . This strongly indicates, that the entire virus life cycle 330 of CPV9 and CPV14, respectively, must have been completed in the respective lesions.
331
Splicing is known to be an important posttranscriptional process for papillomavirus gene The Phylogenetic analysis of the CPV sequences indicates at least two mayor branches 337 containing three or more species within the genus Chi genus of papillomaviruses (Fig. 2) . One 338 branch contains the CPVs 3, 5, 9 and 11 that cluster well together and which would fulfill the 339 criteria of one taxonomic species (>70% identities). CPV4 Appears to be in that branch as 340 well, but it would represent an own species. However, in case of the second branch, which 341 includes CPVs 8, 10 and 14 applying the species definition is not that easy. When looking at 342 CPVs 8 and 10 independently, they would represent two different species (<70% identities), 343 whereas CPV14 seems to be in between fulfilling the criteria for both ( Egawa, N., Nakahara, T., Ohno, S., Narisawa-Saito, M., Yugawa, T., Fujita, M., Yamato, K., Favrot, C., Olivry, T., Werner, A. H., Nespecca, G., Utiger, A., Grest, P., Ackermann, M., Yuan, H., Ghim, S., Newsome, J., Apolinario, T., Olcese, V., Martin, M., Delius, H., showing round electrodense particles in negative stain electromicroscopy; bar 50nm. CPV1 CPV2 CPV3 CPV4 CPV5 CPV6 CPV7 CPV8 CPV9 CPV10 CPV11 CPV14  CPV1  57  54  56  57  69  58  60  58  56  55  58  CPV2  57  55  53  56  56  70  57  55  57  54  55  CPV3  54  55  64  73  53  54  62  72  62  73  61  CPV4  56  53  64  66  56  55  63  67  62  64  63  CPV5  57  56  73  66  56  55  62  71  63  73  61  CPV6  69  56  53  56  56  56  57  54  56  55  55  CPV7  58  70  54  55  55  56  57  55  55  55 
